Presentation
CA 02263961 1999-02-22W0 98/07427 PCT/US97/14702present, and more specifically, any location where a dopamine orserotonin transporter is present. [brevets-patents.ic.gc.ca]
Workup
7.59 (m, 2 H),7.97 (m, 2 H), 10.62 (131: S, 1 H); IR (CHCl,) 3155, 3005, 2930,1690, 1650, 1520, 1450, 1355, 1215 cmâReaction of 0.5 g (1.33 mmol) of 3B-(4-Methy1phenyl)-tropane-2B-N-(phenyacyl)carboxamide as described above for ETI-1B9 gave after workup [brevets-patents.ic.gc.ca]
Treatment
Treatment protocols and experimental therapies are fully described, with guidance on follow-up and monitoring. [link.springer.com]
Current and emerging treatment strategies for neuronal ceroid lipofuscinoses. CNS Drugs. 2019;33(4):315-25. doi: 10.1007/s40263-019-00620-8. [ Links ] 8. Mole S, Williams R, Goebel H. [scielo.org.co]
Med.Chem. 34:2719-2725 (1991)) were treated with dilithiated methylor phenyl acetoneoximes, obtained by the treatment of acetone oracetophenoneoxime with n-BuLi at 0°C. [brevets-patents.ic.gc.ca]